| 产品详情 |
| Edit |   |
| Product Name | ML-184 |
| Description | Purity >97%. GPR55 is a G protein-coupled receptor that is weakly activated by some cannabinoids (CBs) at nM concentrations but displays a 5- to 10-fold greater stimulation in response to 1 µM lysophosphatidylinositol (LPI). ML-184 is a potent synthetic agonist of GPR55 (EC50 = 0.26 µM). It does not act at the related kynurenic acid receptor GPR35 and is a weak antagonist of CB1 and CB2 (IC50s = 21.8 and 15.1 µM, respectively). Like LPI, ML-184 induces phosphorylation of ERK1/2 and translocation of PKC beta II to the plasma membrane by activating GPR55. |
| Size | n/a |
| Concentration | n/a |
| Applications | n/a |
| Other Names | 3-[[4-(2,3-dimethylphenyl)-1-piperazinyl]carbonyl]-N,N-dimethyl-4-(1-pyrrolidinyl)-benzenesulfonamide, CID-2440433 |
| Gene, Accession, CAS # | CAS: 794572-10-4 |
| Catalog # | LS-H142 |
| Price | |
| Order / More Info | ML-184 from LIFESPAN BIOSCIENCES INC. |
| Product Specific References | n/a |
| 产品资料 |
|
|